Related references
Note: Only part of the references are listed.15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
Ki Rim Kim et al.
PLOS ONE (2015)
Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts
Ah Young Jun et al.
INVESTIGATIONAL NEW DRUGS (2014)
Colony-stimulating factor 1 potentiates lung cancer bone metastasis
Jaclyn Y. Hung et al.
LABORATORY INVESTIGATION (2014)
Targeting tumor-stromal interactions in bone metastasis
Mark Esposito et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment
Se Young Park et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Targeted treatments of bone metastases in patients with lung cancer
Vera Hirsh
FRONTIERS IN ONCOLOGY (2014)
Runx3 Inactivation Is a Crucial Early Event in the Development of Lung Adenocarcinoma
You-Soub Lee et al.
CANCER CELL (2013)
CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
Taku Kato et al.
CYTOKINE (2013)
Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma
Zhe Jin et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Biochemical-markers for the diagnosis of bone metastasis: A clinical review
Qian Huang et al.
CANCER EPIDEMIOLOGY (2012)
Models of Bone Metastasis
J. Preston Campbell et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
DNA methylation profile during multistage progression of pulmonary adenocarcinomas
Jin-Haeng Chung et al.
VIRCHOWS ARCHIV (2011)
Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis
Ya-Ling Hsu et al.
CARCINOGENESIS (2010)
Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients
Eleni M. Karapanagiotou et al.
MEDICAL ONCOLOGY (2010)
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid
Giannis Mountzios et al.
TRANSLATIONAL RESEARCH (2010)
Suppression of Metastatic Murine Ovarian Cancer Cells by Transduced Embryonic Progenitor Cells
Masaki Mandai et al.
Hormones & Cancer (2010)
Tumor-Stromal Interactions in Bone Metastasis
Kalyan C. Nannuru et al.
Current Osteoporosis Reports (2010)
CCL5 increases lung cancer migration via PI3K Akt and NF-kappa B pathways
Chun-Yin Huang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
CCL5/CCR5 Axis Promotes the Motility of Human Oral Cancer Cells
Jing-Yuan Chuang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Prevention and Management of Bone Metastases in Lung Cancer A Review
Hamed Al Husaini et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment
Morgan O'Hayre et al.
BIOCHEMICAL JOURNAL (2008)
RANK ligand as a therapeutic target for bone metastases and multiple myeloma
G. David Roodman et al.
CANCER TREATMENT REVIEWS (2008)
Lung adenocarcinoma invasion in TGFbRII-deficient cells is mediated by CCL5/RANTES
A. C. Borczuk et al.
ONCOGENE (2008)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
Veselina Goranova-Marinova et al.
HAEMATOLOGICA (2007)
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone
J. Pratap et al.
CANCER AND METASTASIS REVIEWS (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder
Sami Tsukishiro et al.
GYNECOLOGIC ONCOLOGY (2006)
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen et al.
CLINICAL CANCER RESEARCH (2006)
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
Gaoping Chen et al.
CANCER (2006)
Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells
XL Yang et al.
VACCINE (2006)
RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4
Eliane Shizuka Nakamura et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis
PJ Hensbergen et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog
CA Yoshida et al.
GENES & DEVELOPMENT (2004)
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-γ-dependent antitumor responses in a lung cancer model
S Hillinger et al.
JOURNAL OF IMMUNOLOGY (2003)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
Share Paper
